Although the effects of the long-term use of the aforementioned compounds are currently unknown, these findings encourage further approaches to target impaired MRTF-A/SRF signaling and thereby ameliorate devastating cardiac diseases associated with LMNA mutations. The gene discussed is LMNA; the disease is heart disorder.